⌘K

Brainstorm Cell Therapeutics Inc. (BCLI)

$0.26 -7.04% $-0.02 Healthcare

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Market cap

$20.53M

CEO

Mr. Chaim Lebovits

Full time employees

43.00

Headquarters

New York, NY

IPO Date

May 28, 2003

Price-to-earnings (PE) Ratio

-1.17

Earnings-per-share (EPS)

$-0.22

Cash ratio (TTM)

0.45

Current ratio (TTM)

0.50

Net profit margin (TTM)

-9,169.78%

PE ratio (TTM)

-1.55

PEG ratio (TTM)

-0.04

Price-to-book ratio (TTM)

-5.59

Price-to-sales ratio (TTM)

158.89

Quick ratio (TTM)

0.50

Return on assets (TTM)

-224.28%

Return on equity (TTM)

308.68%

Similar stocks (21)

Edgewise Therapeutics, Inc.

EWTX

$17.52 0.29% $0.05

Neutral

Day One Biopharmaceuticals, Inc.

DAWN

$14.20 -2.07% $-0.30

Downtrend

Celcuity Inc.

CELC

$15.06 -4.02% $-0.63

Downtrend

Terns Pharmaceuticals, Inc.

TERN

$7.81 4.69% $0.35

Uptrend

C4 Therapeutics, Inc.

CCCC

$5.40 -7.38% $-0.43

Downtrend

Aldeyra Therapeutics, Inc.

ALDX

$6.13 -3.01% $-0.19

Uptrend

Inozyme Pharma, Inc.

INZY

$4.98 -4.60% $-0.24

Downtrend

Corvus Pharmaceuticals, Inc.

CRVS

$4.03 0.75% $0.03

Uptrend

Trevi Therapeutics, Inc.

TRVI

$2.95 -4.84% $-0.15

Uptrend

Generation Bio Co.

GBIO

$2.18 -6.03% $-0.14

Downtrend

aTyr Pharma, Inc.

LIFE

$1.90 2.70% $0.05

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.65 -3.51% $-0.02

Downtrend

Checkpoint Therapeutics, Inc.

CKPT

$2.10 -2.33% $-0.05

Neutral

Werewolf Therapeutics, Inc.

HOWL

$2.02 -0.98% $-0.02

Downtrend

BioAtla, Inc.

BCAB

$1.74 -5.95% $-0.11

Downtrend

Protalix BioTherapeutics, Inc.

PLX

$1.00 -1.96% $-0.02

Downtrend

Passage Bio, Inc.

PASG

$0.70 9.98% $0.06

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.02 -0.97% $-0.01

Downtrend

Cue Biopharma, Inc.

CUE

$0.59 -6.35% $-0.04

Downtrend

HCW Biologics Inc.

HCWB

$0.70 25.66% $0.14

Downtrend

Cohen & Steers Global Realty Majors ETF

GRI

$0.51 4.29% $0.02

Downtrend

ETF Exposure (7)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$129.08 -1.69% $-2.22

Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$92.34 -1.71% $-1.61

Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

$92.32 -1.71% $-1.61

Neutral

Vanguard Total Stock Market Index Fund

VITSX

$129.67 -1.71% $-2.25

Neutral

Vanguard Total Stock Market Index Fund

VTI

$266.44 -1.66% $-4.50

Neutral

Vanguard Total Stock Market Index Fund

VTSAX

$129.65 -1.71% $-2.25

Neutral

Vanguard Extended Market Index Fund

VXF

$170.15 -1.70% $-2.94

Neutral

Downtrend

Similar stocks (21)

Edgewise Therapeutics, Inc.

EWTX

$17.52 0.29% $0.05

Neutral

Day One Biopharmaceuticals, Inc.

DAWN

$14.20 -2.07% $-0.30

Downtrend

Celcuity Inc.

CELC

$15.06 -4.02% $-0.63

Downtrend

Terns Pharmaceuticals, Inc.

TERN

$7.81 4.69% $0.35

Uptrend

C4 Therapeutics, Inc.

CCCC

$5.40 -7.38% $-0.43

Downtrend

Aldeyra Therapeutics, Inc.

ALDX

$6.13 -3.01% $-0.19

Uptrend

Inozyme Pharma, Inc.

INZY

$4.98 -4.60% $-0.24

Downtrend

Corvus Pharmaceuticals, Inc.

CRVS

$4.03 0.75% $0.03

Uptrend

Trevi Therapeutics, Inc.

TRVI

$2.95 -4.84% $-0.15

Uptrend

Generation Bio Co.

GBIO

$2.18 -6.03% $-0.14

Downtrend

aTyr Pharma, Inc.

LIFE

$1.90 2.70% $0.05

Downtrend

X4 Pharmaceuticals, Inc.

XFOR

$0.65 -3.51% $-0.02

Downtrend

Checkpoint Therapeutics, Inc.

CKPT

$2.10 -2.33% $-0.05

Neutral

Werewolf Therapeutics, Inc.

HOWL

$2.02 -0.98% $-0.02

Downtrend

BioAtla, Inc.

BCAB

$1.74 -5.95% $-0.11

Downtrend

Protalix BioTherapeutics, Inc.

PLX

$1.00 -1.96% $-0.02

Downtrend

Passage Bio, Inc.

PASG

$0.70 9.98% $0.06

Downtrend

AN2 Therapeutics, Inc.

ANTX

$1.02 -0.97% $-0.01

Downtrend

Cue Biopharma, Inc.

CUE

$0.59 -6.35% $-0.04

Downtrend

HCW Biologics Inc.

HCWB

$0.70 25.66% $0.14

Downtrend

Cohen & Steers Global Realty Majors ETF

GRI

$0.51 4.29% $0.02

Downtrend

ETF Exposure (7)

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$129.08 -1.69% $-2.22

Neutral

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$92.34 -1.71% $-1.61

Neutral

Vanguard Institutional Total Stock Market Index Fund

VITPX

$92.32 -1.71% $-1.61

Neutral

Vanguard Total Stock Market Index Fund

VITSX

$129.67 -1.71% $-2.25

Neutral

Vanguard Total Stock Market Index Fund

VTI

$266.44 -1.66% $-4.50

Neutral

Vanguard Total Stock Market Index Fund

VTSAX

$129.65 -1.71% $-2.25

Neutral

Vanguard Extended Market Index Fund

VXF

$170.15 -1.70% $-2.94

Neutral